Trials / Completed
CompletedNCT00885274
A Randomized Controlled Trial Comparing Two Timing Regimens of Pico-salax for Colon Cleansing Prior to Colonoscopy
A Randomized Controlled Trial Comparing Two Timing Regimens of Pico-salax for Colon Cleansing Prior to Colonoscopy.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 250 (actual)
- Sponsor
- Queen's University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Pico-Salax is an osmotic and stimulant bowel cleansing agent used prior to colonoscopy. It is unknown whether splitting the doses (i.e. taking the second dose the morning of the colonoscopy) results in a better bowel cleansing, as research with other agents suggests this may be the case. This study aims to assess whether splitting the dose of Pico-Salax results in a better bowel cleansing than traditional dosing.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pico-Salax | Both doses of Pico-Salax taken the evening prior to colonoscopy |
| DRUG | Split Dose Pico-Salax | One dose of Pico-Salax taken the evening prior to colonoscopy and the other the morning of the procedure. |
Timeline
- Start date
- 2008-11-01
- Primary completion
- 2011-03-01
- Completion
- 2011-08-01
- First posted
- 2009-04-21
- Last updated
- 2015-08-31
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT00885274. Inclusion in this directory is not an endorsement.